Research & Development (Preclinical Lab APIs)

LGM Pharma is a premier API solutions provider, with over 2,500 high quality Active Pharmaceutical Ingredients.

LGM Pharma assists laboratories and biotech companies throughout the entire cycle of drug development.

We provide strong regulatory support and documentation for your regulatory filings. LGM Pharma’s materials are accompanied by the proper regulatory certifications and has hundreds of SKUs in stock that are ready to ship.

The APIs listed below are the main Research & Development that are presently available from LGM Pharma:
LGM Pharma is a preferred supplier to the biotech and pharmaceutical industry. From university and government labs, to the largest generic and specialty pharmaceutical companies, LGM caters to the requirements of its clients in all stages of drug development and commercialization. We offer our clients full API and regulatory support, from R&D quantities, to clinical batches, to full commercial manufacturing. By working closely with API manufacturers worldwide, LGM has developed a reputation in the industry for being able to deliver rare molecules, related compounds that are difficult to source, or simply cost efficient APIs that are manufactured with a “smart” quality manufacturing process.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. We’re working to update our website to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service